These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3737653)

  • 1. HPLC determination of benzydamine and its metabolite N-oxide in plasma following oral administration or topical application in man, using fluorimetric detection.
    Catanese B; Lagana A; Marino A; Picollo R; Rotatori M
    Pharmacol Res Commun; 1986 Apr; 18(4):385-403. PubMed ID: 3737653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of benzydamine following the topical use of this drug in gynecology.
    Catanese B; Facchini V; Barillari G; Putzolu S
    Clin Exp Obstet Gynecol; 1980; 7(2):84-8. PubMed ID: 7249354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of benzydamine in vaginal mucosa following local application: an experimental and clinical study.
    Maamer M; Aurousseau M; Colau JC
    Int J Tissue React; 1987; 9(2):135-45. PubMed ID: 3610512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects.
    Baldock GA; Brodie RR; Chasseaud LF; Taylor T; Walmsley LM; Catanese B
    Biopharm Drug Dispos; 1991 Oct; 12(7):481-92. PubMed ID: 1932611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of benzydamine.
    Schoenwald RD; Kumakura T; Catanese B
    Int J Tissue React; 1987; 9(2):93-7. PubMed ID: 3610518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of benzydamine and its N-oxide in biological fluids by high-performance liquid chromatography.
    Baldock GA; Brodie RR; Chasseaud LF; Taylor T
    J Chromatogr; 1990 Jul; 529(1):113-23. PubMed ID: 2211924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of benzydamine.
    Chasseaud LF; Catanese B
    Int J Tissue React; 1985; 7(3):195-204. PubMed ID: 4044147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human plasma metabolic profiles of benzydamine, a flavin-containing monooxygenase probe substrate, simulated with pharmacokinetic data from control and humanized-liver mice.
    Yamazaki-Nishioka M; Shimizu M; Suemizu H; Nishiwaki M; Mitsui M; Yamazaki H
    Xenobiotica; 2018 Feb; 48(2):117-123. PubMed ID: 28145791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of pharmacological data on benzydamine.
    Cioli V; Corradino C; Scorza Barcellona P
    Int J Tissue React; 1985; 7(3):205-13. PubMed ID: 3899969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of topical benzydamine in gynecology.
    Bentivoglio G; Diani F
    Clin Exp Obstet Gynecol; 1981; 8(3):103-10. PubMed ID: 7042126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Photocontact allergy caused by benzydamine (Tantum)].
    Frosch PJ; Weickel R
    Hautarzt; 1989 Dec; 40(12):771-3. PubMed ID: 2533588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I Study in Healthy Women of a Novel Antimycotic Vaginal Ovule Combining Econazole and Benzydamine.
    Di Stefano AFD; Radicioni MM; Vaccani A; Caccia G; Focanti F; Salvatori E; Pelacchi F; Picollo R; Rosignoli MT; Olivieri S; Bovi G; Comandini A
    Infect Dis Obstet Gynecol; 2020; 2020():7201840. PubMed ID: 32410819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of topical benzydamine hydrochloride gel on oral mucosal ulcers: an in vivo animal study.
    Karavana Hizarcioğlu SY; Sezer B; Güneri P; Veral A; Boyacioğlu H; Ertan G; Epstein JB
    Int J Oral Maxillofac Surg; 2011 Sep; 40(9):973-8. PubMed ID: 21549562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence study of two liquid formulations of benzydamine.
    Catanese B; Lagana A; Curini L; Del Bosco M; Colloca A
    Biopharm Drug Dispos; 1988; 9(1):113-8. PubMed ID: 3342282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topical treatment of thrombophlebitis with feprazone and benzydamine. Controlled clinical study].
    Bagliani A; Montalbetti L
    Minerva Med; 1976 Mar; 67(14):880-4. PubMed ID: 772478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzydamine N-oxygenation as a measure of flavin-containing monooxygenase activity.
    Yeung CK; Rettie AE
    Methods Mol Biol; 2006; 320():157-62. PubMed ID: 16719388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatography assay for the measurement of benzydamine hydrochloride in topical pharmaceutical preparations.
    Benson HA; McElnay JC
    J Chromatogr; 1987 May; 394(2):395-9. PubMed ID: 3624346
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of benzydamine for treatment of vaginitis: results of a randomized study with emphasis on functional symptoms.
    Bremond A
    Int J Tissue React; 1987; 9(2):147-9. PubMed ID: 3610513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience in the use of 0.5% and 1% benzydamine cream in vaginal inflammation].
    Mega M; Becagli L
    Minerva Ginecol; 1986; 38(7-8):625-30. PubMed ID: 3748443
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of benzydamine HCl for the management of cancer therapy-induced mucositis: preliminary report of a multicentre study.
    Schubert MM; Newton RE
    Int J Tissue React; 1987; 9(2):99-103. PubMed ID: 3610519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.